The Influence of Prednisone on the Efficacy of Cabazitaxel in Men with Metastatic Castration-Resistant Prostate Cancer (Q41721844)

8 October 2017

The Influence of Prednisone on the Efficacy of Cabazitaxel in Men with Metastatic Castration-Resistant Prostate Cancer (English)

1 reference

8 October 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28928853%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Martina Pagliuca

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28928853%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

author name string

Guru Sonpavde

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28928853%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Francesca Vitrone

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28928853%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Davide Bosso

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28928853%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Livio Puglia

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28928853%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Michela Izzo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28928853%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Simona Iaccarino

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28928853%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Luca Scafuri

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28928853%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Margherita Muratore

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28928853%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Francesca Foschini

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28928853%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Brigitta Mucci

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28928853%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Vincenzo Tortora

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28928853%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Dario Ribera

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28928853%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Vittorio Riccio

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28928853%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Rocco Morra

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28928853%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Mirta Mosca

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28928853%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Nicola Cesarano

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28928853%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Ileana Di Costanzo

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28928853%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Sabino De Placido

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28928853%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Giuseppe Di Lorenzo

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28928853%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

publication date

22 August 2017

1 reference

8 October 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28928853%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28928853%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

page(s)

2663-2668

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28928853%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

issue

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28928853%20AND%20SRC:MED&resulttype=core&format=json

Contemporary agents in the management of metastatic castration-resistant prostate cancer.

13 June 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5604196

Impact of single-agent daily prednisone on outcomes in men with metastatic castration-resistant prostate cancer

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5604196

The emerging role of obesity, diet and lipid metabolism in prostate cancer

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5604196

The influence of prednisone on the efficacy of docetaxel in men with metastatic castration-resistant prostate cancer

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5604196

Lack of Cumulative Toxicity Associated With Cabazitaxel Use in Prostate Cancer

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5604196

Low-dose prednisolone in first-line docetaxel for patients with metastatic castration-resistant prostate cancer: is there a clinical benefit?

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5604196

Global cancer statistics, 2012

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5604196

Preclinical profile of cabazitaxel

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5604196

Prostate-specific antigen flare induced by cabazitaxel-based chemotherapy in patients with metastatic castration-resistant prostate cancer

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5604196

Real-world cabazitaxel safety: the Italian early-access program in metastatic castration-resistant prostate cancer

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5604196

Potential value of Gleason score in predicting the benefit of cabazitaxel in metastatic castration-resistant prostate cancer.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5604196

Abiraterone in metastatic prostate cancer without previous chemotherapy

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5604196

Abiraterone and increased survival in metastatic prostate cancer

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5604196

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5604196

Is enough attention being given to the adverse effects of corticosteroid therapy?

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5604196

Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5604196

Treatment of metastatic prostatic cancer with low-dose prednisone: evaluation of pain and quality of life as pragmatic indices of response

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5604196

Contemporary molecular tests for prognosis and treatment guidance for castration-resistant prostate cancer.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5604196

Poor survival in prostate cancer patients with primary refractoriness to docetaxel.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5604196

The development of risk groups in men with metastatic castration-resistant prostate cancer based on risk factors for PSA decline and survival

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5604196

Potential mechanism for the effects of dexamethasone on growth of androgen-independent prostate cancer.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5604196

Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5604196

Rapidly progressive disease in a castration-resistant prostate cancer patient after cabazitaxel discontinuation

18 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28928853

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Role of glucocorticoids in the physiopathology of excessive fat deposition and insulin resistance

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28928853

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.7150/JCA.20040

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28928853%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28928853%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

1 reference